Remove Clinical Trials Remove Legislation Remove Treatment
article thumbnail

Survey: Three Of Four Military Veterans Would Consider Using Medical Cannabis

NORML

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

article thumbnail

A Bipartisan Bill Is Pledging $75 Million for Psychedelic Research in Military PTSD Treatment

Veriheal

This article will delve into this historic legislation’s potential benefits and implications. The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. With this step, the U.S. This could foster a pool of experts well-versed in applying psychedelic-assisted therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Forward-Looking Statements. Los Angeles, California.

article thumbnail

Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Cannabis Law Report

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. DENVER, Dec.

article thumbnail

Bionomics Announces Plans to Conduct U.S. Initial Public Offering

Cannabis Law Report

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co.,

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep.

article thumbnail

Missouri Republican,Michael Davis, proposes adding access to LSD, MDMA, peyote, and psilocybin as treatment options

Cannabis Law Report

Wednesday, Representative Michael Davis, R-Kansas City, proposed legislation that would modify Missouri’s existing ‘Right-to-Try’ law. Federal approval in the form of the 2018 “Right to Try Act,” has since opened more doors and created new treatment options for patients.